For the Inventor, By the Inventor

Enter assignee name

Stoughton, MA, United States of America

Collegium Pharmaceutical, Inc.

USPTO Granted Patents = 28

% Expired Patents = 35.7

EPO Patents = 2

Trademarks = 11

Forward Citations = 617

Loading Chart...

Loading Chart...

17 inventors (with patents filed for the assignee):

Jane C Hirsh (20 out of 21 patents)

Roman V Rariy (20 out of 23 patents)

Alison B Fleming (19 out of 19 patents)

4. Alexander M Klibanov (9 out of 39 patents)

5. Said Saim (8 out of 24 patents)

6. Ravi K Varanasi (8 out of 10 patents)

7. Timothy Manning Swager (4 out of 123 patents)

8. Stephen L Buchwald (4 out of 55 patents)

9. Michael Heffernan (4 out of 5 patents)

10. Mark Hirsh (4 out of 9 patents)

11. Whe-Yong Lo (3 out of 6 patents)

12. Srinivas G Rao (2 out of 20 patents)

13. Whe Yong Lo (2 out of 2 patents)

14. Shubha Chungi (2 out of 2 patents)

15. Kamal K Midha (2 out of 12 patents)

Core Competencies:

Abuse-Deterrent

Tamper-Resistant

Pharmaceutical Compositions

Oral Formulations

Sleep Disorders

Modified Release

Milnacipran

Stereoisomers

Sedative Antihistamines

Non-Sedative Antihistamines

28 patents: Sort by Forward Citations

1. 10668060 - Tamper-resistant pharmaceutical compositions of opioids and other drugs (2020-06-02),

2. 10646485 - Process of making stable abuse-deterrent oral formulations (2020-05-12),

3. 10525053 - Abuse-deterrent pharmaceutical compositions of opioids and other drugs (2020-01-07),

4. 10525052 - Abuse-deterrent drug formulations (2020-01-07),

5. 10188644 - Process of making stable abuse-deterrent oral formulations (2019-01-29),

6. 10004729 - Tamper-resistant pharmaceutical compositions of opioids and other drugs (2018-06-26),

7. 9968598 - Process of making stable abuse-deterrent oral formulations (2018-05-15),

8. 9763883 - Abuse-deterrent drug formulations (2017-09-19),

9. 9737530 - Process of making stable abuse-deterrent oral formulations (2017-08-22),

10. 9682075 - Tamper-resistant pharmaceutical compositions of opioids and other drugs (2017-06-20),

11. 9592200 - Abuse-deterrent pharmaceutical compositions of opioids and other drugs (2017-03-14),

12. 9248195 - Abuse-deterrent pharmaceutical compositions of opioids and other drugs (2016-02-02),

13. 9044398 - Abuse-deterrent pharmaceutical compositions of opiods and other drugs (2015-06-02),

14. 8840928 - Tamper-resistant pharmaceutical compositions of opioids and other drugs (2014-09-23),

15. 8758813 - Abuse-deterrent drug formulations (2014-06-24),

Collegium Pharmaceutical, Inc. is a biopharmaceutical company based in Stoughton, Massachusetts, focused on developing innovative treatments for patients suffering from pain and related conditions. The company specializes in advanced drug delivery technologies and formulations, aiming to improve the efficacy and safety of pain management therapies. Collegium is committed to addressing unmet medical needs through its research and development efforts, leveraging its expertise in pharmacology and patient-centered solutions.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

28 Patents

#2 in Stoughton, MA

#714 in Massachusetts

#11,997 in US

#23,244 in the World

Stoughton, MA, United States of America

Collegium Pharmaceutical, Inc.

Forward Citations = 617

17 inventors:

Jane C Hirsh (20 out of 21 patents)

Roman V Rariy (20 out of 23 patents)

Alison B Fleming (19 out of 19 patents)

4. Alexander M Klibanov (9 out of 39 patents)

5. Said Saim (8 out of 24 patents)

Please report any incorrect information to [email protected]

Loading…